Mirtazapin versus andre antidepressive laegemidler til behandling af depression - en gennemgang af et Cochranereview
Engelsk titel: Mirtazapine versus other antidepressive agents for depression
Läs online
Författare:
Larsen, Jens Knud
Email: jens.knud.larsen@regionh.dk
Språk: Dan
Antal referenser: 10
Dokumenttyp:
Kommentar
UI-nummer: 12127716
Sammanfattning
A Cochrane analysis compared efficacy and side effects of mirtazapine with other antidepressants. After six weeks of treatment no reliable difference of efficacy between mirtazapine, selective serotonin reuptake inhibitors (SSRI), noradrenaline reuptake inhibitors or tricyclic antidepressants was found. The side effects like increased sleep and weight gain were compared by treatment with mirtazapine and treatment with SSRI antidepressants. The very fact of the sleep effect and the fast onset of action have probably increased the effect size compared with SSRI antidepressants. The results of the Cochrane analysis cannot for certain be generalized to inpatients, as other studies have found tricyclic antidepressants to be especially effective.